Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:959-965
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, V.
Right arrow Articles by Hambrecht, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, V.
Right arrow Articles by Hambrecht, R.

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

Volker Adams, PhDa, Hong Jiang, MDa, Jiangtao Yu, MDa, Sven Möbius-Winkler, BSa, Eduard Fiehn, MDa, Axel Linke, BSa, Claudia Weigl, MDa, Gerhard Schuler, MDa and Rainer Hambrecht, MDa

a Clinic for Internal Medicine/Cardiology, University of Leipzig, Herzzentrum GmbH, Leipzig, Germany



View larger version (134K):

[in a new window]
 
Figure 1 Representative images (x200) of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling reactions or antiactin staining of skeletal muscle biopsies. Nuclei with fragmented deoxyribonucleic acid stained red (arrows) (A) whereas cells with normal nuclei stained blue (immunoperoxidase staining with hematoxylin counterstaining). Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling staining of a skeletal muscle biopsy from a (A) chronic heart failure (CHF) patient; (B) normal control subject; (C) CHF patient after deoxyribonuclease I pretreatment; (D) CHF patient after deoxyribonuclease I pretreatment but with the omission of deoxynucleotidyl transferase in the labeling reaction; (E) CHF patient, and (F) the same as in (E) but counterstained with antiactin is shown. The identical nuclei in E and F are marked with asterisks.

 


View larger version (145K):

[in a new window]
 
Figure 2 Representative images of the immunohistochemical detection of inducible nitric oxide synthase (A, B) or Bcl-2 (C, D) of a skeletal muscle biopsy from a chronic heart failure patient (A, C) and a normal control subject (C, D) (x200).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement